These findings that mHLA‐DR+ and PD‐1 + CD4‐CD8‐T predict mortality risk early in the course of sepsis may contribute to improved models of sepsis‐related immune dysregulation, risk‐stratification, and personalized treatment strategies. This evidence concerns the gene PDCD1 and Sepsis.